Jeffrey R. Marks - Concepedia

Author

Jeffrey R. Marks

Also Known As

Adam A. Margolin, Angeles Secord, Byoung-Gie Kim, Daniel J. Brat, Douglas A. Levine, Edwin S Iversen, Fabienne Lesueur, Fadlo Khuri, Finkelstein, Dianne M., Florian Markowetz

590

Publications

46K

Citations

H-Index

167

Concepts

All Affiliations

Duke Medical Center Duke University Duke University Hospital The University of Texas MD Anderson Cancer Center Dana-Farber Cancer Institute

About

Jeffrey R. Marks is an author at Duke Medical Center specializing in medicine, tumor biology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	55	96	16.5K
2	Engineering	12	15	4.3K
3	Health Sciences	2	2	253
4	Business	1	1	31
5	Education	1	1	122

Jeffrey R. Marks

196

Publications

26.4K

Citations

H-Index

Page 1

	Year	Citations
Oncogenic pathway signatures in human cancers as a guide to targeted therapies Andrea Bild, Guang Yao, Jeffrey T. Chang, Nature Oncogenic Pathway SignaturesRadiation OncologySystems BiologyOncologyEngineering	2005	2.1K
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer Giovanni Ciriello, Michael L. Gatza, Andrew H. Beck, Cell Breast OncologyComprehensive Molecular PortraitsMedicinePathologyCancer Genomics	2015	1.9K
Predicting the clinical status of human breast cancer by using gene expression profiles Mike West, Carrie Blanchette, Holly K. Dressman, Proceedings of the National Academy of Sciences Breast OncologyPathologyHuman Breast CancerGene Expression ProfilesGene Expression Profiling	2001	1.3K
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines Kyle Ellrott, Matthew H. Bailey, Gordon Saksena, Cell Systems EngineeringGeneticsGenomicsArtifact FilteringTcga Data	2018	895
Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene Expression Carey K. Anders, David S. Hsu, Gloria Broadwater, Journal of Clinical Oncology	2008	878
Genomic signatures to guide the use of chemotherapeutics Anil Potti, Holly K. Dressman, Andrea Bild, Nature Medicine Genomic SignaturesBiomolecular ToolTumor HeterogeneityComputational BiologyMolecular Biology	2006	593
Overexpression and mutation of p53 in epithelial ovarian cancer. Jeffrey R. Marks, A M Davidoff, B. J. Kerns, PubMed Tumoral PathologyCancer PathologyEpithelial Ovarian CancerMedicineP53 Expression	1991	471
Compromised HOXA5 function can limit p53 expression in human breast tumours Venu Raman, Shelby A. Martensen, David Reisman, Nature Hoxa5 FunctionHuman Breast TumoursBreast OncologyMedicineP53 Expression	2000	468
High frequency of hypermethylation at the 14-3-3 σ locus leads to gene silencing in breast cancer Anne Ferguson, Ella Evron, Christopher B. Umbricht, Proceedings of the National Academy of Sciences	2000	442
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas Franz X. Schaub, Varsha Dhankani, Ashton C. Berger, Cell Systems	2018	434

Page 1